Endeavor

10,000th Bone Marrow Transplant Gives Sarasota Man a Second Chance

Patient’s journey highlights the teamwork and innovation behind Moffitt Cancer Center’s 10,000th transplant

Single-Drug Immunotherapy Shows Success in Rare Skin Cancer

Pembrolizumab delivers 89% response rate in desmoplastic melanoma, sparing patients from harsher combination treatments

Spreading Education, Awareness Around Clinical Trials

ACT WONDER2S team hosts sessions in the community to provide straightforward information and dispel myths

Welcoming Speros President Josh Carpenter, DPhil

Josh Carpenter, DPhil, joins Moffitt with the task of guiding one of the most ambitious life sciences initiatives in the nation

New Moffitt Chef Is Cooking Toward a Cure

Chef brings new flavors and expertise to cancer center's Population Engagement and Research Laboratory

FDA Approval Brings Hope for Patients With Rare Neuroendocrine Tumors

Moffitt researchers help bring new therapy to patients with limited treatment options

Dendritic Cell Vaccines Changing Landscape for Breast Cancer Treatment

Moffitt research shows promise in breakthrough immunotherapy treatment

Improving Outcomes for Patients With Synovial Sarcoma

Moffitt treats first patient in the world with FDA-approved Tecelra

Lung Cancer Patient Strives To Make a Difference

Ed Cutler joined two clinical trials after his diagnosis